Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Kineta Inc.
KACurrent price
0.67 USD
-0.06 USD (-8.22%)
Last closed
0.72 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
7 045 400 USD
Yield for 12 month
-81.49 %
1Y
3Y
5Y
10Y
15Y
KA
Kineta, Inc. is a clinical-stage biotechnology company with a focus on developing immunotherapies that transform patients' lives. It focuses on developing potentially differentiated immunotherapies that address the challenges with current cancer therapy. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (mAb) infusion drug. KVA12123 is being evaluated in a Phase 1/2 clinical trial as a monotherapy and in combination with pembrolizumab in patients with advanced solid tumors, including non-small cell lung, ovarian, renal cell carcinoma, head and neck, renal cell, and colorectal cancers. It is also developing anti-CD27 agonist mAb immunotherapy to address the problem of exhausted T cells. The company has collaboration and license agreements with MSD International Business GmbH, Genentech, Inc., FAIR Therapeutics B.V., and GigaGen, Inc. Kineta, Inc. is headquartered in Seattle, Washington. Address: 219 Terry Ave. N, Seattle, WA, United States, 98109
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
13.5 USDP/E ratio
–Dividend Yield
–Current Year
+5 442 000 USD
Last Year
+1 953 000 USD
Current Quarter
–
Last Quarter
–
Current Year
+5 433 000 USD
Last Year
+1 219 000 USD
Current Quarter
–
Last Quarter
-2 726 000 USD
Key Figures KA
1 year
3 years
5 years
10 years
EBITDA
-17 241 500 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-114.08 %
PEG Ratio
–
Return On Equity TTM
-369.01 %
Wall Street Target Price
13.5 USD
Revenue TTM
–
Book Value
-0.66 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
9 091 000 USD
Earnings per share
-1.64 USD
Diluted Eps TTM
-1.64 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics KA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
-78 %Dividend History KA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:7
Payout Ratio
–
Last Split Date
19.12.2022
Dividend Date
–
Stock Valuation KA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.2891
Price Sales TTM
1.4373
Enterprise Value EBITDA
-4.5342
Price Book MRQ
9.6506
Financials KA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators KA
For 52 weeks
0.33 USD
4.77 USD
50 Day MA
0.65 USD
Shares Short Prior Month
89 969
200 Day MA
1.12 USD
Short Ratio
0.68
Shares Short
28 541
Short Percent
0.31 %
BeatStart